跳至主要内容
临床试验/CTRI/2024/06/069214
CTRI/2024/06/069214尚未招募2 期

Comparative effectiveness of individualised homoeopathic medicines in lm potencies and centesimal potencies for the management of irritable bowel syndrome: a prospective randomized clinical study

National Institute of Homoeopathy1 个研究点 分布在 1 个国家目标入组 84 人开始时间: 2024年7月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
84
试验地点
1
主要终点
Assessment of increase or decrease in IBS-QOL questionnaire total score in patient

研究概览

简要总结

The study will explore not only the symptomatic relief of IBS using IBS-QOL scores and IBS-SSS scores provided by the respective potencies of Homoeopathic medicine but also consider broader aspects such as quality of life, psychological well-being, and patient satisfaction. Through a comprehensive and randomized approach, this research seeks to enhance our understanding of homoeopathic approaches to IBS but also provide evidence-based guidance for practitioners in choosing between LM and centesimal potencies, thus optimizing individualized treatment strategies for patients suffering from this challenging condition.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patients suffering from IBS as per Rome IV diagnostic criteria b.
  • Both sexes c.
  • Age 18-65 years d.
  • Patients willing to participate in the study and giving written informed consent.
  • Ability to Understand Bengali or Hindi or English.

排除标准

  • Any major gastrointestinal surgery in the last 6 months b.
  • Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or lifethreatening illness affecting the quality of life or any organ failure.
  • Currently receiving standard therapy for IBS and/ or homoeopathic treatment for any chronic condition(s) d.
  • Pregnant and lactating women e.
  • Self-reported immune compromised conditions f.
  • Substance abuse and/or dependence g.
  • Patients who are too sick for consultation.

结局指标

主要结局

Assessment of increase or decrease in IBS-QOL questionnaire total score in patient

时间窗: Baseline and every month up to 6 months of treatment.

suffering from Irritable Bowel Syndrome

时间窗: Baseline and every month up to 6 months of treatment.

次要结局

  • Assessment of increase or decrease in IBS-SSS questionnaire total score in patient(suffering from Irritable Bowel Syndrome)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Subhrajit Paul

National Institute of Homoeopathy

研究点 (1)

Loading locations...

相似试验